A detailed history of Legal & General Group PLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 100,624 shares of RLAY stock, worth $653,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,624
Previous 87,087 15.54%
Holding current value
$653,049
Previous $722,000 9.14%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.9 - $8.02 $79,868 - $108,566
13,537 Added 15.54%
100,624 $656,000
Q1 2024

May 14, 2024

BUY
$7.5 - $12.07 $84,660 - $136,246
11,288 Added 14.89%
87,087 $722,000
Q3 2023

Nov 14, 2023

SELL
$8.24 - $12.97 $6,995 - $11,011
-849 Reduced 1.11%
75,799 $637,000
Q2 2023

Aug 14, 2023

BUY
$9.99 - $18.27 $15,864 - $29,012
1,588 Added 2.12%
76,648 $962,000
Q1 2023

May 15, 2023

BUY
$15.0 - $22.76 $190,890 - $289,643
12,726 Added 20.42%
75,060 $1.24 Million
Q4 2022

Feb 14, 2023

SELL
$14.16 - $24.02 $12,503 - $21,209
-883 Reduced 1.4%
62,334 $931,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $47,704 - $82,816
2,640 Added 4.36%
63,217 $1.41 Million
Q2 2022

Aug 22, 2022

BUY
$13.31 - $34.88 $126,804 - $332,301
9,527 Added 18.66%
60,577 $1.02 Million
Q1 2022

May 16, 2022

BUY
$20.26 - $32.36 $7,820 - $12,490
386 Added 0.76%
51,050 $1.53 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $289,146 - $411,810
11,121 Added 28.12%
50,664 $1.56 Million
Q3 2021

Nov 15, 2021

BUY
$29.75 - $37.99 $188,079 - $240,172
6,322 Added 19.03%
39,543 $1.25 Million
Q2 2021

Aug 12, 2021

BUY
$27.5 - $38.19 $203,307 - $282,338
7,393 Added 28.62%
33,221 $1.22 Million
Q1 2021

May 17, 2021

BUY
$32.52 - $61.53 $395,345 - $748,020
12,157 Added 88.93%
25,828 $893,000
Q4 2020

Feb 12, 2021

SELL
$35.51 - $54.03 $833,100 - $1.27 Million
-23,461 Reduced 63.18%
13,671 $568,000
Q3 2020

Nov 13, 2020

BUY
$32.81 - $45.1 $1.22 Million - $1.67 Million
37,132 New
37,132 $1.58 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.